Gufic Pharma Limited - Due diligence report

A 360° intelligence report on Gufic Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress s…

1983-06-25 Ahmedabad, Gujarat Amalgamated Unlisted
Share
View plans
GP Gufic Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Gufic Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
59/100
Trust Score
Moderate

Gufic Pharma Limited is assessed as Moderate with a Trust Score of 59/100. Gufic Pharma Limited is a public limited indian non-government company incorporated in 1983, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 26 Jun 2026 from the latest processed filings. Gufic Pharma Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
59/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
10/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 7 satisfied (1.36 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank5 48.0 cr
The Saraswat Co-Operative Bank Ltd1 48.0 cr
Bharat Overseas Bank Ltd1 48.0 cr
Compliance Score: 10/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2017 - filings overdue.
  • Litigation present in 3 court forum(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
PRINCE KALARICKAL ELIAS 01234567 Director 01/04/2018 6 yrs Approved
SANJAY JERRY 01234567 Director 01/04/2018 6 yrs Approved
SANDEEP MEHANDROO 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Sun Pharmaceutical Industries Limited
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 5 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Sun Pharmaceutical Industries Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 43+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (10/100).
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence38/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment67/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view43/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
07 Aug 2017
Last AGM held
Annual general meeting
31 Mar 2017
Share transfer (FY 2017)
1.00000000 shares to Kumar Suresh
Share transfer (FY 2017)
1.00000000 shares to Indulal Ashok
Share transfer (FY 2017)
1.00000000 shares to Sharad Meetal
Share transfer (FY 2017)
1.00000000 shares to Virendra Mehul
Share transfer (FY 2017)
1.00000000 shares to Aniruddha
Latest balance sheet
Filed with ROC
28 Sep 2016
Director ceased
PRINCE KALARICKAL ELIAS
28 Jun 2016
Charge satisfied
Canara Bank
20 Jun 2016
Charge satisfied
Bharat Overseas Bank Ltd
20 May 2016
Charge satisfied
The Saraswat Co-Operative Bank Ltd
15 Feb 2016
Director appointed
PRINCE KALARICKAL ELIAS (Director)
Director ceased
MEETAL SHARAD SAMPAT
31 Aug 2015
Director ceased
AKHILESH KUMAR NAND
24 Nov 2014
Director ceased
SUSHIL KUMAR PATAWARI
10

Key Observations

Auto-generated from the data above
3 active director(s) / partner(s); board looks stable and experienced.
All 7 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Amptech Pharmaceutical Private Limited U85100WB2009PTC136250 Howrah, West Bengal, India
Onemed Crew Private Limited U74900PB2014PTC038646 Mohali, Punjab, India
Avani Pharma Private Limited U51397KA2011PTC058775 Bangalore, Karnataka, India
Chanchal Medicare Private Limited U24100MP2015PTC034470 Indore, Madhya Pradesh, India
Vermas Life Line Biotech Private Limited U24232BR2012PTC018648 Patna, Bihar, India
Nodex Pharmaceutical Private Limited U85300OR2013PTC017063 Bhubaneswar, Orissa, India
Phalgun Vincom Private Limited U51909WB2009PTC132942 Kolkata, West Bengal, India
Janish Pharma Private Limited U24231MH2001PTC133686 Thane, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Gufic Pharma Limited before audits and certifications: compliance score 10/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Gufic Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Gufic Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 59/100, distress signals and MSME payment-delay disclosures - know whether Gufic Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Gufic Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Gufic Pharma Limited an active company?

Gufic Pharma Limited has MCA status “Amalgamated” with a compliance score of 10/100 (Caution Indicated).

Is Gufic Pharma Limited financially healthy?

Gufic Pharma Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Gufic Pharma Limited?

Its overall Trust Score is 59/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Gufic Pharma Limited?

The ultimate holding entity is Sun Pharmaceutical Industries Limited. 3 active director(s) are on record.

Does Gufic Pharma Limited have loans or charges against its assets?

No open charges - all 7 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Gufic Pharma Limited up to date with its ROC filings?

Last balance sheet is for Mar 2017 - filings overdue. Overall compliance score: 10/100 (Caution Indicated).

Is it risky to lend to Gufic Pharma Limited?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.